SPRY NASDAQ
ARS Pharmaceuticals, Inc.
1W: -16.1%
1M: -21.3%
3M: -50.4%
YTD: -58.6%
1Y: -54.7%
3Y: -35.5%
5Y: -79.1%
$4.76
-0.30 (-5.93%)
Weekly Expected Move ±11.7%
$4
$4
$5
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$472.7M
52W Range4.73-13.15
Volume2,570,805
Avg Volume1,926,206
Beta0.88
Dividend—
Analyst Ratings
Company Info
CEODonn Casale
Employees195
SectorHealthcare
IndustryBiotechnology
IPO Date2020-12-04
Websitears-pharma.com
11682 El Camino Real
San Diego, CA 92130
US
San Diego, CA 92130
US
858 335 1300
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
Latest News
Brokerages Set ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) PT at $28.20
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Smith Margaret Ekins | A-Award | 1,001,738 | $5.77 | 2026-09-01 |
| Smith Margaret Ekins | 0 | — | 2026-08-17 | |
| Casale Donn | A-Award | 898,456 | $7.96 | 2026-07-01 |
| Shah Pratik | A-Award | 30,000 | $10.54 | 2026-06-24 |
| Kelly Michael | A-Award | 30,000 | $10.54 | 2026-06-24 |